Oral: COVID-19 Drugs and Vaccines

Home / Oral: COVID-19 Drugs and Vaccines

Oral: COVID-19 Drugs and Vaccines

Predictive Primates: Enabling Rapid Go/No-Go Decisions on COVID-19 Vaccine Candidates with a Predictive, Translational MBMA and Clinical Immunogenicity Data

Thursday 16 October, 2025

Objectives: The Covid-19 pandemic is motivating extraordinarily rapid development of safe and efficacious vaccines against SARS-CoV-2, increasing the need for…

Read more

Using population approach to model COVID-19 epidemics in France: estimating the burden of SARS-Cov-2 and the effects of non-pharmaceutical interventions.

Thursday 16 October, 2025

Objectives: The COVID-19 disease is an ongoing pandemics of coronavirus infection caused by SARS-CoV-2. Governments are taking a wide range…

Read more

Modeling SARS-CoV-2 viral kinetics in hospitalized patients

Thursday 16 October, 2025

Objectives: A detailed characterization of viral load kinetics and its association with disease evolution is a key not only to…

Read more